BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37488785)

  • 21. VEGF-C expression in squamous cell carcinoma and adenocarcinoma of the esophagus.
    Möbius C; Freire J; Becker I; Feith M; Brücher BLDM; Hennig M; Siewert JR; Stein HJ
    World J Surg; 2007 Sep; 31(9):1768-1772. PubMed ID: 17354029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence and survival for gastric and esophageal cancer diagnosed in British Columbia, 1990 to 1999.
    Bashash M; Shah A; Hislop G; Brooks-Wilson A; Le N; Bajdik C
    Can J Gastroenterol; 2008 Feb; 22(2):143-8. PubMed ID: 18299732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trend in incidence of adenocarcinoma of the esophagus in Japan, 1993-2001.
    Shibata A; Matsuda T; Ajiki W; Sobue T
    Jpn J Clin Oncol; 2008 Jul; 38(7):464-8. PubMed ID: 18664481
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences in colorectal cancer survival between European and US populations: the importance of sub-site and morphology.
    Gatta G; Ciccolallo L; Capocaccia R; Coleman MP; Hakulinen T; Møller H; Berrino F;
    Eur J Cancer; 2003 Oct; 39(15):2214-22. PubMed ID: 14522381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trends and projections in adenocarcinoma and squamous cell carcinoma of the oesophagus in England from 1971 to 2037.
    Offman J; Pesola F; Sasieni P
    Br J Cancer; 2018 May; 118(10):1391-1398. PubMed ID: 29563637
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increasing incidence of both major histological types of esophageal carcinomas among men in Sweden.
    Hansson LE; Sparén P; Nyrén O
    Int J Cancer; 1993 May; 54(3):402-7. PubMed ID: 8509215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Time trends incidence of both major histologic types of esophageal carcinomas in selected countries, 1973-1995.
    Vizcaino AP; Moreno V; Lambert R; Parkin DM
    Int J Cancer; 2002 Jun; 99(6):860-8. PubMed ID: 12115489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changing incidence of gastric and oesophageal cancer subtypes in central Switzerland between 1982 and 2007.
    Schmassmann A; Oldendorf MG; Gebbers JO
    Eur J Epidemiol; 2009; 24(10):603-9. PubMed ID: 19669623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changing pattern of esophageal cancer incidence in New Mexico.
    Vega KJ; Jamal MM
    Am J Gastroenterol; 2000 Sep; 95(9):2352-6. PubMed ID: 11007241
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regional variations in esophageal cancer rates by census region in the United States, 1999-2008.
    Drahos J; Wu M; Anderson WF; Trivers KF; King J; Rosenberg PS; Eheman C; Cook MB
    PLoS One; 2013; 8(7):e67913. PubMed ID: 23861830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Esophageal adenocarcinoma versus squamous cell carcinoma: retrospective hospital-based analysis of a 12-year temporal trend.
    Bhome R; Desai D; Abraham P; Joshi A; Gupta T; Bhaduri A; Kapadia A; Patel K; Bhome R
    Indian J Gastroenterol; 2012 Dec; 31(6):340-2. PubMed ID: 22983840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Esophageal cancer: Risk factors, screening and endoscopic treatment in Western and Eastern countries.
    Domper Arnal MJ; Ferrández Arenas Á; Lanas Arbeloa Á
    World J Gastroenterol; 2015 Jul; 21(26):7933-43. PubMed ID: 26185366
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clustering and geographic variation of upper gastrointestinal cancers in a high-risk region of esophageal cancer in northern China.
    Zhang N; Wen D; Shan B; Wang S; Zhang L; Wei L; Zou W; Kitsu K; Akazawa K
    Asian Pac J Cancer Prev; 2011; 12(1):193-8. PubMed ID: 21517256
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreasing trend of esophageal adenocarcinoma in Hong Kong.
    Yee YK; Cheung TK; Chan AO; Yuen MF; Wong BC
    Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2637-40. PubMed ID: 18086768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Current epidemiology of carcinoma of the esophagus and cardia in Germany].
    Bareiss D; Stabenow R; Müller R; Eisinger B; Stegmaier C; Däubler P; Zeitz M; Scherübl H
    Dtsch Med Wochenschr; 2002 Jun; 127(25-26):1367-74. PubMed ID: 12075496
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sex differences in the prognosis after surgery for esophageal squamous cell carcinoma and adenocarcinoma.
    Kauppila JH; Wahlin K; Lagergren P; Lagergren J
    Int J Cancer; 2019 Mar; 144(6):1284-1291. PubMed ID: 30168595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changing trends in esophageal cancer: a 15-year experience in a single center.
    Sharma VK; Chockalingam H; Hornung CA; Vasudeva R; Howden CW
    Am J Gastroenterol; 1998 May; 93(5):702-5. PubMed ID: 9625112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trends in the subsite and morphology of oesophageal and gastric cancer in England and Wales 1971-1998.
    Newnham A; Quinn MJ; Babb P; Kang JY; Majeed A
    Aliment Pharmacol Ther; 2003 Mar; 17(5):665-76. PubMed ID: 12641515
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of Intraoperative Opioid Use on Recurrence-Free and Overall Survival in Patients With Esophageal Adenocarcinoma and Squamous Cell Carcinoma.
    Du KN; Feng L; Newhouse A; Mehta J; Lasala J; Mena GE; Hofstetter WL; Cata JP
    Anesth Analg; 2018 Jul; 127(1):210-216. PubMed ID: 29757780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.